The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts
S Bazarbashi, HM El Zawahry, T Owaidah… - Journal of Blood …, 2024 - Taylor & Francis
Venous thromboembolism is a leading cause of morbidity and mortality in patients with
active cancer who require anticoagulation treatment. Choice of anticoagulant is based on …
active cancer who require anticoagulation treatment. Choice of anticoagulant is based on …
[HTML][HTML] The Daily US News Updates
S Bazarbashi, HM El Zawahry, T Owaidah, MA AlBader… - thedailyusnews.com
Venous thromboembolism is a leading cause of morbidity and mortality in patients with
active cancer who require anticoagulation treatment. Choice of anticoagulant is based on …
active cancer who require anticoagulation treatment. Choice of anticoagulant is based on …